Page 48 - JCBP-3-3
P. 48

Journal of Clinical and
            Basic Psychosomatics                                                  Microbiota in psychosomatic disorders



            83.  Kang D, Park JG, Ilhan ZE,  et al. Reduced incidence of   2011;2(4):256‑261.
               prevotella and other fermenters in intestinal microflora of      doi: 10.4161/gmic.2.4.16108
               autistic children. PLoS One. 2013;8(7):e68322.
                                                               93.  Schmidt K, Cowen PJ, Harmer CJ, Tzortzis G, Errington S,
               doi: 10.1371/journal.pone.0068322
                                                                  Burnet  PWJ.  Prebiotic  intake  reduces  the  waking  cortisol
            84.  Fond G, Loundou A, Hamdani N,  et al. Anxiety and   response and alters emotional bias in healthy volunteers.
               depression comorbidities in irritable bowel syndrome (IBS):   Psychopharmacology. 2014;232(10):1793‑1801.
               A systematic review and meta-analysis. Eur Arch Psychiatry      doi: 10.1007/s00213‑014‑3810‑0
               Clin Neurosci. 2014;264(8):651‑660.
                                                               94.  Freijy TM, Cribb L, Oliver G, et al. Effects of a high-prebiotic
               doi: 10.1007/s00406‑014‑0502‑z
                                                                  diet versus probiotic supplements versus synbiotics on adult
            85.  Maier  KJ,  Al’Absi  M.  Toward  a  biopsychosocial  ecology   mental  health:  The  “Gut  Feelings”  randomised  controlled
               of the human microbiome, brain-gut axis, and health.   trial. Front Neurosci. 2023;16:1097278.
               Psychosom Med. 2017;79(8):947‑957.
                                                                  doi: 10.3389/fnins.2022.1097278
               doi: 10.1097/PSY.0000000000000515
                                                               95.  Jacka FN, O’Neil A, Opie R, et al. A randomised controlled
            86.  Kabra N, Nadkarni A. Prevalence of depression and anxiety   trial of dietary improvement for adults with major depression
               in  irritable  bowel  syndrome:  A  clinic  based  study  from   (the “SMILES” trial). BMC Med. 2017;15(1):23.
               India. Indian J Psychiatry. 2013;55(1):77.
                                                                  doi: 10.1186/s12916‑017‑0791‑y
               doi: 10.4103/0019‑5545.105520
                                                               96.  Olson CA, Vuong HE, Yano JM, Liang QY, Nusbaum DJ,
            87.  Bisgaard TH, Allin KH, Keefer L, Ananthakrishnan AN,   Hsiao EY. The gut microbiota mediates the Anti-Seizure
               Jess T. Depression and anxiety in inflammatory bowel   effects of the ketogenic diet.  Cell.  2018;173(7):1728‑
               disease: Epidemiology, mechanisms and treatment. Nat Rev   1741.e13.
               Gastroenterol Hepatol. 2022;19(11):717‑726.
                                                                  doi: 10.1016/j.cell.2018.04.027
               doi: 10.1038/s41575‑022‑00634‑6
                                                               97.  Sun Y, Ju P, Xue T, Ali U, Cui D, Chen J. Alteration of faecal
            88.  Mikocka‑Walus  A,  Pittet  V,  Rossel  J,  et al. Symptoms of   microbiota  balance  related  to long-term deep  meditation.
               depression and anxiety are independently associated with   Gen Psychiatry. 2023b;36(1):e100893.
               clinical recurrence of inflammatory bowel disease. Clin      doi: 10.1136/gpsych‑2022‑100893
               Gastroenterol Hepatol. 2016;14(6):829‑835.e1.
                                                               98.  Lackner  JM,  Jaccard  J,  Keefer  L,  et al. Improvement in
               doi: 10.1016/j.cgh.2015.12.045
                                                                  gastrointestinal symptoms after cognitive behavior therapy
            89.  Cao Y, Shen J, Ran ZH. Association between Faecalibacterium   for  refractory  irritable  bowel  syndrome.  Gastroenterology.
               prausnitzii  reduction  and  inflammatory  bowel  disease:   2018;155(1):47‑57.
               A  meta-analysis  and  systematic  review  of  the  literature.
               Gastroenterol Res Pract. 2014;2014:872725.         doi: 10.1053/j.gastro.2018.03.063
                                                               99.  Halkjær SI, Christensen AH, Lo BZS, et al. Faecal microbiota
               doi: 10.1155/2014/872725
                                                                  transplantation alters gut microbiota in patients with irritable
            90.  Khorsand  B,  Aghdaei  HA,  Nazemalhosseini-Mojarad  E,   bowel syndrome: Results from a randomised, double‑blind
               Nadalian B, Nadalian B, Houri H. Overrepresentation of   placebo-controlled study. Gut. 2018;67(12):2107‑2115.
               Enterobacteriaceae and  Escherichia  coli is the major gut      doi: 10.1136/gutjnl‑2018‑316434
               microbiome signature in Crohn’s disease and ulcerative
               colitis; a comprehensive metagenomic analysis of IBDMDB   100. Kurilshikov A, Medina-Gomez C, Bacigalupe R, et al. Large-
               datasets. Front Cell Infect Microbiol. 2022;12:1015890.  scale association analyses identify host factors influencing
                                                                  human gut microbiome composition. Nat Genet. 2021;
               doi: 10.3389/fcimb.2022.1015890
                                                                  53(2):156‑165.
            91.  Kazemi A, Noorbala AA, Azam K, Eskandari MH,
               Djafarian K. Effect of probiotic and prebiotic vs placebo      doi: 10.1038/s41588‑020‑00763‑1
               on psychological outcomes in patients with major   101.  Vona R, Pallotta L, Cappelletti M, Severi C, Matarrese P. The
               depressive disorder: A randomized clinical trial. Clin Nutr.   impact  of  oxidative  stress  in  human  pathology:  Focus  on
               2018;38(2):522‑528.                                gastrointestinal disorders. Antioxidants (Basel). 2021;10(2):201.
               doi: 10.1016/j.clnu.2018.04.010                    doi: 10.3390/antiox10020201
            92.  Messaoudi M, Violle N, Bisson J, Desor D, Javelot H, Rougeot   102. Hills RD Jr., Pontefract BA, Mishcon HR, Black CA,
               C. Beneficial psychological effects of a probiotic formulation   Sutton  SC,  Theberge  CR.  Gut  microbiome:  Profound
               (Lactobacillus  helveticus R0052 and  Bifidobacterium   implications for diet and disease.  Kompass Nutr Diet.
               longum R0175) in healthy human volunteers. Gut Microbes.   2022;2(1):3‑18.


            Volume 3 Issue 3 (2025)                         42                         doi: 10.36922/JCBP025040008
   43   44   45   46   47   48   49   50   51   52   53